prednisolone has been researched along with Cholangiitis, Sclerosing in 54 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient received treatment by prednisolone and thereafter developed bladder cancer and gastric cancer." | 4.84 | [ case of autoimmune pancreatitis with various extrapancreatic fibrosclerosis followed by malignant diseases]. ( Arai, O; Hirao, K; Katayama, S; Matsueda, K; Miyoshi, M; Mouri, H; Notohara, K; Yamamoto, H, 2008) |
| "Treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) with ursodeoxycholic acid (UDCA) has been in common use since 1985." | 4.81 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. ( Holtmeier, J; Leuschner, U, 2001) |
| "MODE OF ACTION OF URSODEOXYCHOLIC ACID: In cholestasis, the impaired biliary secretion of toxic bile acids causes their accumulation in the liver and a subsequent hepatic failure." | 4.81 | [Treatment of cholestatic liver diseases]. ( Gatzen, M; Pausch, J, 2002) |
| " At 26 years of age, he was found to have eosinophilia and abnormal liver function parameters, for which prednisolone therapy was started." | 3.80 | Concurrent primary sclerosing cholangitis and eosinophilic colitis. ( Fujiwara, T; Gunji, N; Katakura, K; Ohira, H; Suzuki, R; Takahashi, A; Watanabe, H, 2014) |
| "The clinical course of our patient suggests the association between chronic pancreatitis and primary sclerosing cholangitis (PSC), as well as the usefulness of prednisolone for the treatment of this condition." | 3.70 | Primary sclerosing pancreatitis and cholangitis. ( Adachi, K; Arima, N; Ashizawa, N; Hirakawa, K; Kazumori, H; Kinoshita, Y; Moriyama, N; Tamura, K; Watanabe, M, 1998) |
| "Severe alcoholic hepatitis (AH) is a life-threatening condition lacking good serologic markers to tailor treatment and predict recovery." | 2.87 | Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis. ( Färkkilä, M; Nissinen, M; Sahlman, P; Simonen, P, 2018) |
| "We report a case of primary sclerosing cholangitis (PSC) with autoimmune hemolytic anemia (AIHA)." | 2.72 | Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature. ( Abe, M; Amano, K; Arinaga-Hino, T; Ide, T; Kawaguchi, T; Kunitake, K; Kuwahara, R; Mizuochi, S; Morishige, S; Nagafuji, K; Sano, T; Torimura, T, 2021) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) represent acute and chronic inflammatory liver diseases in which immune reactions against host antigens are found to be the major pathological mechanism." | 2.41 | [Autoimmune hepatitis and overlap syndrome: therapy]. ( Löhr, HF, 2002) |
| "Prednisolone was administered orally, after which the biliary tract and hepatic enzyme levels improved immediately." | 1.62 | Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report. ( Hattori, N; Kawamoto, K; Matsumoto, N; Nabeshima, S; Nishi, Y; Ohashi, N; Takaki, S; Taniwaki, M; Yamasaki, M, 2021) |
| "Immune checkpoint inhibitors (ICIs), particularly anti-PD-1 antibody, have dramatically changed cancer treatment; however, fatal immune-related adverse events (irAEs) can develop." | 1.62 | A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. ( Arai, J; Ariizumi, H; Hamada, K; Hirasawa, Y; Horiike, A; Imamura, CK; Ishida, H; Ishiguro, T; Iwamoto, S; Kiuchi, Y; Kobayashi, S; Kubota, Y; Matsui, H; Oguro, N; Ohkuma, R; Sakaki, M; Sambe, T; Shida, M; Shiozawa, E; Taniguchi, M; Tate, G; Tsunoda, T; Tsurutani, J; Uchida, N; Wada, S; Yoshimura, K, 2021) |
| "Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is often associated with type 1 autoimmune pancreatitis, and the frequency of isolated IgG4-SC seems to be quite low, making the diagnosis of isolated IgG4-SC challenging." | 1.48 | Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis. ( Abe, M; Harada, K; Hiasa, Y; Imamura, Y; Koizumi, M; Kumagi, T; Kuroda, T; Ohno, Y; Takeshita, E; Tokumoto, Y; Watanabe, T; Yoshida, O, 2018) |
| "Prednisolone was started from 40 mg daily, tapered gradually, and totally withdrawn after 22 months of treatment." | 1.48 | A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse. ( Dong, X; Huo, N; Wang, G; Wang, H; Wu, Z; Zhao, H, 2018) |
| "Even following transplantation, recurrence of PSC is seen in approximately one quarter of patients and leads to high rates of graft failure." | 1.46 | Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation. ( Gow, P; Hey, P; Johnson, P; Lokan, J, 2017) |
| "Immunoglobulin G4 sclerosing cholangitis (IgG4-SC) is a biliary tract manifestation of IgG4-related systemic disease." | 1.46 | Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis. ( Chiba, T; Inui, K; Nakazawa, T; Okazaki, K; Takikawa, H; Tanaka, A; Tazuma, S, 2017) |
| "Tacrolimus was started on 16/17 (94%) patients due to insufficient response to standard therapy." | 1.43 | Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. ( Adams, DH; Füssel, K; Hirschfield, GM; Hodson, J; Lohse, AW; Mann, J; Oo, YH; Schramm, C; Than, NN; Weiler-Normann, C; Wiegard, C, 2016) |
| "Retrospective review of AILD [autoimmune hepatitis type 1 and 2 (AIH1, AIH2), primary sclerosing cholangitis (PSC) and autoimmune sclerosing cholangitis (ASC)] seen at two pediatric liver units in Malaysia." | 1.42 | Characteristics and outcome of autoimmune liver disease in Asian children. ( Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM, 2015) |
| "IgG4-related sclerosing cholangitis (IgG4-SC) and primary biliary cirrhosis (PBC) can both cause liver dysfunction." | 1.38 | A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis. ( Hayashi, K; Joh, T; Kondo, H; Miyabe, K; Naitoh, I; Nakazawa, T; Nojiri, S; Shimizu, S; Takahashi, S; Yamashita, H; Yoshida, M, 2012) |
| "Although rare, the diagnosis of sclerosing cholangitis with GEL is important in view of its excellent and apparently sustained response to immunosuppressive treatment." | 1.38 | Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. ( Grammatikopoulos, T; Heneghan, MA; Mieli-Vergani, G; Portmann, BC; Vergani, D; Zen, Y, 2012) |
| "Although an orbital pseudotumor is a rare extrapancreatic lesion of AIP, we should know that AIP patients may describe unusual symptoms such as abnormal visual field." | 1.37 | Visual field deficit: a rare initial symptom of autoimmune pancreatitis. ( Egawa, N; Horiguchi, S; Inaba, Y; Kamisawa, T; Ozaki, N; Tabata, T; Takuma, K; Takuma, S, 2011) |
| "Sclerosing cholangitis is one of the extrapancreatic lesions that are commonly detected in AIP patients; it is detected on ultrasonographic imaging as characteristic wall thickening." | 1.35 | Ultrasonographic imaging of bile duct lesions in autoimmune pancreatitis. ( Honjo, H; Imamura, T; Koyama, R; Okuda, C; Sakamoto, N; Takeuchi, K, 2008) |
| "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive fibrosis and destruction of intra- and extrahepatic bile ducts resulting in hepatic failure and death." | 1.34 | [A case of sclerosing cholangitis showing response to prednisolone]. ( Hwang, JS; Jang, BK; Jang, YS; Kang, MK; Kang, YN; Kwon, JH; Park, KS; Shin, YS, 2007) |
| "Ursodeoxycholic acid (UDCA) treatment for primary sclerosing cholangitis (PSC) has been considered a rational therapy, though its effectiveness in the clinical course is still open to discussion." | 1.31 | Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. ( Kikuchi, S; Kisara, N; Komatsu, K; Maruhama, Y; Shimosegawa, T; Toyota, T; Uchi, M; Ueno, Y, 2000) |
| "Treatment with ursodeoxycholic acid (250 mg three times daily) and prednisolone (initially 2 mg/kg daily) quickly led to normal biochemical values and regression of the eye changes." | 1.29 | [Angioimmunoblastic lymphadenopathy with dysproteinemia and sclerosing cholangitis]. ( Garbrecht, M; Nerl, C; Schmitt, W; Wegerle, W, 1994) |
| "The association of sclerosing cholangitis, retroperitoneal fibrosis, and Riedel's thyroiditis has been reported twice before, and on both occasions the authors successfully used steroids to control the fibrotic process." | 1.28 | Sclerosing cholangitis associated with multifocal fibrosis: a case report. ( Buckels, JA; Darby, S; Elias, E; Hubscher, SG; Laitt, RD, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (12.96) | 18.2507 |
| 2000's | 21 (38.89) | 29.6817 |
| 2010's | 19 (35.19) | 24.3611 |
| 2020's | 7 (12.96) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, S | 1 |
| Miyazaki, M | 2 |
| Morita, Y | 1 |
| Tanaka, K | 1 |
| Yada, M | 1 |
| Masumoto, A | 1 |
| Motomura, K | 1 |
| Yassin, S | 1 |
| De Lacy, R | 1 |
| Pillay, K | 1 |
| Goddard, E | 1 |
| McClure, T | 1 |
| Cui, W | 1 |
| Asadi, K | 1 |
| John, T | 1 |
| Testro, A | 1 |
| Kawaguchi, T | 1 |
| Arinaga-Hino, T | 1 |
| Morishige, S | 1 |
| Mizuochi, S | 1 |
| Abe, M | 3 |
| Kunitake, K | 1 |
| Sano, T | 1 |
| Amano, K | 1 |
| Kuwahara, R | 1 |
| Ide, T | 1 |
| Nagafuji, K | 1 |
| Torimura, T | 1 |
| Nabeshima, S | 1 |
| Yamasaki, M | 1 |
| Matsumoto, N | 1 |
| Takaki, S | 1 |
| Nishi, Y | 1 |
| Kawamoto, K | 1 |
| Taniwaki, M | 1 |
| Ohashi, N | 1 |
| Hattori, N | 1 |
| Hirasawa, Y | 1 |
| Yoshimura, K | 1 |
| Matsui, H | 1 |
| Kubota, Y | 1 |
| Ishida, H | 1 |
| Arai, J | 1 |
| Sakaki, M | 1 |
| Oguro, N | 1 |
| Shida, M | 1 |
| Taniguchi, M | 1 |
| Hamada, K | 1 |
| Ariizumi, H | 1 |
| Ishiguro, T | 1 |
| Ohkuma, R | 1 |
| Sambe, T | 1 |
| Horiike, A | 1 |
| Imamura, CK | 1 |
| Shiozawa, E | 1 |
| Wada, S | 1 |
| Tsurutani, J | 1 |
| Iwamoto, S | 1 |
| Uchida, N | 1 |
| Kiuchi, Y | 1 |
| Tate, G | 1 |
| Kobayashi, S | 1 |
| Tsunoda, T | 1 |
| Zhou, T | 1 |
| Fronhoffs, F | 1 |
| Dold, L | 1 |
| Strassburg, CP | 2 |
| Weismüller, TJ | 1 |
| Yang, X | 1 |
| Xu, H | 1 |
| Yang, J | 1 |
| Yang, L | 1 |
| Hey, P | 1 |
| Lokan, J | 1 |
| Johnson, P | 1 |
| Gow, P | 1 |
| Ohno, Y | 1 |
| Kumagi, T | 1 |
| Imamura, Y | 1 |
| Kuroda, T | 1 |
| Koizumi, M | 1 |
| Watanabe, T | 2 |
| Yoshida, O | 1 |
| Tokumoto, Y | 1 |
| Takeshita, E | 1 |
| Harada, K | 1 |
| Hiasa, Y | 1 |
| Sahlman, P | 1 |
| Nissinen, M | 1 |
| Simonen, P | 1 |
| Färkkilä, M | 1 |
| Dong, X | 1 |
| Huo, N | 1 |
| Wu, Z | 1 |
| Wang, G | 1 |
| Wang, H | 1 |
| Zhao, H | 1 |
| Noble-Jamieson, G | 1 |
| Heuschkel, RB | 1 |
| Torrente, F | 1 |
| Hadzic, N | 1 |
| Zilbauer, M | 1 |
| Chun, SW | 1 |
| Choi, JS | 1 |
| Kang, BD | 1 |
| Kim, YJ | 1 |
| Han, KJ | 1 |
| Cho, HG | 1 |
| Oh, HE | 1 |
| Cho, JH | 1 |
| You, MW | 1 |
| Kim, JH | 1 |
| Byun, JH | 1 |
| Kim, HJ | 1 |
| Lee, SS | 1 |
| Kim, MH | 1 |
| Lee, MG | 1 |
| Masutani, H | 1 |
| Okuwaki, K | 1 |
| Kida, M | 1 |
| Yamauchi, H | 1 |
| Imaizumi, H | 1 |
| Miyazawa, S | 1 |
| Iwai, T | 1 |
| Takezawa, M | 1 |
| Koizumi, W | 1 |
| Gunji, N | 1 |
| Katakura, K | 1 |
| Takahashi, A | 1 |
| Fujiwara, T | 1 |
| Suzuki, R | 1 |
| Watanabe, H | 1 |
| Ohira, H | 1 |
| Lee, WS | 1 |
| Lum, SH | 1 |
| Lim, CB | 1 |
| Chong, SY | 1 |
| Khoh, KM | 1 |
| Ng, RT | 1 |
| Teo, KM | 1 |
| Boey, CC | 1 |
| Pailoor, J | 1 |
| Than, NN | 1 |
| Wiegard, C | 1 |
| Weiler-Normann, C | 1 |
| Füssel, K | 1 |
| Mann, J | 1 |
| Hodson, J | 1 |
| Hirschfield, GM | 1 |
| Lohse, AW | 2 |
| Adams, DH | 1 |
| Schramm, C | 2 |
| Oo, YH | 1 |
| Grønbaek, H | 1 |
| Kreutzfeldt, M | 1 |
| Kazankov, K | 1 |
| Jessen, N | 1 |
| Sandahl, T | 1 |
| Hamilton-Dutoit, S | 1 |
| Vilstrup, H | 1 |
| J Møller, H | 1 |
| Tanaka, A | 1 |
| Tazuma, S | 1 |
| Okazaki, K | 1 |
| Nakazawa, T | 2 |
| Inui, K | 1 |
| Chiba, T | 2 |
| Takikawa, H | 1 |
| Koyama, R | 1 |
| Imamura, T | 1 |
| Okuda, C | 1 |
| Sakamoto, N | 1 |
| Honjo, H | 1 |
| Takeuchi, K | 1 |
| Chung, H | 1 |
| Kudo, M | 1 |
| Maenishi, O | 1 |
| Wakatsuki, Y | 1 |
| Takuma, K | 1 |
| Kamisawa, T | 1 |
| Tabata, T | 1 |
| Inaba, Y | 1 |
| Egawa, N | 1 |
| Ozaki, N | 1 |
| Horiguchi, S | 1 |
| Takuma, S | 1 |
| Heras, M | 1 |
| Saiz, A | 1 |
| Fernández-Reyes, MJ | 1 |
| Sánchez, R | 1 |
| Molina, A | 1 |
| Rodríguez, MA | 1 |
| Alvarez-Ude, F | 1 |
| Naitoh, I | 1 |
| Hayashi, K | 1 |
| Miyabe, K | 1 |
| Shimizu, S | 1 |
| Kondo, H | 1 |
| Yoshida, M | 1 |
| Yamashita, H | 1 |
| Nojiri, S | 1 |
| Takahashi, S | 1 |
| Joh, T | 1 |
| Zen, Y | 1 |
| Grammatikopoulos, T | 1 |
| Heneghan, MA | 1 |
| Vergani, D | 2 |
| Mieli-Vergani, G | 2 |
| Portmann, BC | 1 |
| Kuroiwa, T | 1 |
| Suda, T | 1 |
| Takahashi, T | 1 |
| Hirono, H | 1 |
| Natsui, M | 1 |
| Motoyama, H | 1 |
| Nomoto, M | 1 |
| Aoyagi, Y | 1 |
| Löhr, HF | 1 |
| Kadokawa, Y | 1 |
| Omagari, K | 1 |
| Matsuo, I | 1 |
| Otsu, Y | 1 |
| Yamamoto, U | 1 |
| Nishino, T | 1 |
| Ohba, K | 1 |
| Harada, T | 1 |
| Taguchi, T | 1 |
| Kohno, S | 1 |
| Boberg, KM | 1 |
| Egeland, T | 1 |
| Schrumpf, E | 1 |
| Rust, C | 1 |
| Beuers, U | 1 |
| Nishimoto, T | 1 |
| Kiriyama, K | 1 |
| Yabu, M | 1 |
| Kato, T | 1 |
| Yamamoto, S | 1 |
| Himeno, S | 1 |
| Maier, KP | 1 |
| Yüksel, I | 1 |
| Dağli, U | 1 |
| Ataseven, H | 1 |
| Sahin, B | 1 |
| Kodama, M | 1 |
| Murakami, K | 1 |
| Okimoto, T | 1 |
| Takayama, A | 1 |
| Shiota, S | 1 |
| Yasaka, S | 1 |
| Otsu, S | 1 |
| Ono, M | 1 |
| Yoshiiwa, A | 1 |
| Fujioka, T | 1 |
| Shin, YS | 1 |
| Jang, YS | 1 |
| Kang, MK | 1 |
| Jang, BK | 1 |
| Park, KS | 1 |
| Hwang, JS | 1 |
| Kwon, JH | 1 |
| Kang, YN | 1 |
| Arai, O | 1 |
| Matsueda, K | 1 |
| Katayama, S | 1 |
| Hirao, K | 1 |
| Miyoshi, M | 1 |
| Mouri, H | 1 |
| Notohara, K | 1 |
| Yamamoto, H | 1 |
| Wegerle, W | 1 |
| Garbrecht, M | 1 |
| Nerl, C | 1 |
| Schmitt, W | 1 |
| Kazumori, H | 1 |
| Ashizawa, N | 1 |
| Moriyama, N | 1 |
| Arima, N | 1 |
| Hirakawa, K | 1 |
| Adachi, K | 1 |
| Watanabe, M | 1 |
| Kinoshita, Y | 1 |
| Tamura, K | 1 |
| Masumoto, T | 1 |
| Ninomiya, T | 1 |
| Michitaka, K | 1 |
| Horiike, N | 1 |
| Yamamoto, K | 1 |
| Akbar, SM | 1 |
| Onji, M | 1 |
| Zenia, M | 1 |
| Toda, G | 1 |
| Schirmacher, P | 1 |
| Helmreich-Becker, I | 1 |
| Gerken, G | 1 |
| zum Büschenfelde, KH | 1 |
| Angulo, P | 1 |
| Lindor, KD | 1 |
| Yonemitsu, H | 1 |
| Kimura, T | 1 |
| Kagawa, K | 1 |
| Iwanami, E | 1 |
| Tsuda, T | 1 |
| Komatsu, K | 1 |
| Shimosegawa, T | 1 |
| Kikuchi, S | 1 |
| Uchi, M | 1 |
| Maruhama, Y | 1 |
| Kisara, N | 1 |
| Ueno, Y | 1 |
| Toyota, T | 1 |
| Parkes, M | 1 |
| Booth, JC | 1 |
| Pillai, G | 1 |
| Mee, AS | 1 |
| Holtmeier, J | 1 |
| Leuschner, U | 1 |
| Delèvaux, I | 1 |
| André, M | 1 |
| Chipponi, J | 1 |
| Milési-Lecat, AM | 1 |
| Déchelotte, P | 1 |
| Aumaître, O | 1 |
| Gatzen, M | 1 |
| Pausch, J | 1 |
| Laitt, RD | 1 |
| Hubscher, SG | 1 |
| Buckels, JA | 1 |
| Darby, S | 1 |
| Elias, E | 1 |
| Matsuzaki, Y | 1 |
| Yamada, T | 1 |
| Takehara, K | 1 |
| Matsumoto, T | 1 |
| Yuasa, K | 1 |
| Arai, T | 1 |
| Takezawa, J | 1 |
| Nagamine, T | 1 |
| Yamada, S | 1 |
| Mori, M | 1 |
10 reviews available for prednisolone and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature.
Topics: Anemia, Hemolytic, Autoimmune; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing | 2021 |
[Autoimmune hepatitis and overlap syndrome: therapy].
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; | 2002 |
Autoimmune hepatitis in children.
Topics: Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; HLA-DR3 | 2002 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Apoptosis; Cholangitis, Sclerosing; Humans; Immunosuppressive Agents; Liver | 2005 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
[Autoimmune liver diseases and their overlap syndromes].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath | 2006 |
[ case of autoimmune pancreatitis with various extrapancreatic fibrosclerosis followed by malignant diseases].
Topics: Aged; Autoimmune Diseases; Cholangitis, Sclerosing; Humans; Immunocompromised Host; Kidney Neoplasms | 2008 |
[Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combin | 1999 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Co | 2001 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics | 2002 |
1 trial available for prednisolone and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Cholangitis, Sclerosing; Cholestanol; Cholesterol | 2018 |
43 other studies available for prednisolone and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Cholangitis, Sclerosing; Female; Humans; Neopl | 2021 |
Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa.
Topics: Autoantibodies; Azathioprine; Biopsy; Child; Child, Preschool; Cholangiopancreatography, Magnetic Re | 2020 |
Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Biopsy; Cholangiopancreatography, Magnetic Reson | 2020 |
Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Bile Ducts; C | 2021 |
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Cholangiopancreat | 2021 |
New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?
Topics: 2019-nCoV Vaccine mRNA-1273; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotr | 2022 |
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Di | 2017 |
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Co | 2017 |
Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis.
Topics: Bile Ducts, Intrahepatic; Cholangiopancreatography, Endoscopic Retrograde; Cholangiopancreatography, | 2018 |
A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse.
Topics: Aged; Anti-Inflammatory Agents; Cholangitis, Sclerosing; Drug Administration Schedule; Humans; Immun | 2018 |
Colitis-associated sclerosing cholangitis in children: a single centre experience.
Topics: Adolescent; Alanine Transaminase; Anti-Inflammatory Agents; Biopsy; Child; Cholagogues and Cholereti | 2013 |
[A case of IgG4 associated sclerosing cholangitis without clinical manifestations of autoimmune pancreatitis].
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Bile Ducts, Intrahepatic; Cholangiopancreatogra | 2013 |
Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors.
Topics: Adult; Aged; Bile Duct Diseases; Cholangiography; Cholangitis, Sclerosing; Female; Humans; Immunoglo | 2014 |
First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Ch | 2014 |
Concurrent primary sclerosing cholangitis and eosinophilic colitis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Biopsy; Cholangiopancreatography, Endoscopic Retrog | 2014 |
Characteristics and outcome of autoimmune liver disease in Asian children.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangit | 2015 |
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholan | 2016 |
Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biom | 2016 |
Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cholangitis, Sclerosing; Female; Humans; Immunoglobulin G; Ja | 2017 |
Ultrasonographic imaging of bile duct lesions in autoimmune pancreatitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoimmune Diseases; Bile Ducts; Cholangio | 2008 |
Identification and characterization of IgG4-associated autoimmune hepatitis.
Topics: Adult; Aged; Cholangitis, Sclerosing; Female; Glucocorticoids; Hepatitis C, Chronic; Hepatitis, Auto | 2010 |
Visual field deficit: a rare initial symptom of autoimmune pancreatitis.
Topics: Aged; Autoimmune Diseases; Cholangitis, Sclerosing; Dacryocystitis; Humans; Immunoglobulin G; Male; | 2011 |
Primary sclerosing cholangitis and interstitial nephropathy: an emerging association?
Topics: Aged; Cholangitis, Sclerosing; Comorbidity; Female; Humans; Immunoglobulin G; Nephritis, Interstitia | 2012 |
A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis.
Topics: Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunoglobulin G; Liver Cirrhosis, Bilia | 2012 |
Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Bile Ducts; Biopsy; Child; Child, Preschool; Cholagogu | 2012 |
Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid.
Topics: Administration, Oral; Aged; Autoimmune Diseases; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; | 2002 |
Primary sclerosing cholangitis associated with lupus nephritis: a rare association.
Topics: Biopsy, Needle; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; Follow-Up Studies; Human | 2003 |
Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Cholangitis, Sclerosing; Fe | 2003 |
[A case of sclerosing cholangitis trigered by 5-FU/leucovorine combination therapy and rapidly deteriorated].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangitis, Sclerosing; Colonic Neoplasms; Co | 2005 |
Sclerosing cholangitis associated with Wegener's granulomatosis.
Topics: Adult; Anti-Inflammatory Agents; Cholangitis, Sclerosing; Cyclophosphamide; Diagnosis, Differential; | 2006 |
[Sclerosing cholangitis with autoimmune pancreatitis which resembles cholangiocarcinoma].
Topics: Aged; Autoimmune Diseases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Cholangiocarci | 2007 |
[A case of sclerosing cholangitis showing response to prednisolone].
Topics: Adult; Anti-Inflammatory Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Scler | 2007 |
[Angioimmunoblastic lymphadenopathy with dysproteinemia and sclerosing cholangitis].
Topics: Adult; Bile Ducts; Biopsy, Needle; Blood Protein Disorders; Cholangiopancreatography, Endoscopic Ret | 1994 |
Primary sclerosing pancreatitis and cholangitis.
Topics: Anti-Inflammatory Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; | 1998 |
Three patients with autoimmune cholangiopathy treated with prednisolone.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Biopsy, Needle; Cholangitis, Sclerosing; Female; Foll | 1998 |
Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
Topics: Adult; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination | 1999 |
Medical treatment for primary sclerosing cholangitis: risk versus benefit.
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Prednisolone; Ursodeoxycho | 2000 |
[A case of primary sclerosing cholangitis having autoimmune hepatitis-resembling clinical features at the onset of illness].
Topics: Adult; Anti-Inflammatory Agents; Cholangiography; Cholangitis, Sclerosing; Endoscopes; Hepatitis, Au | 2000 |
Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Betame | 2000 |
Do steroids help jaundice caused by primary sclerosing cholangitis?
Topics: Administration, Oral; Aged; Blood Chemical Analysis; Cholangitis, Sclerosing; Drug Administration Sc | 2001 |
A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.
Topics: Adult; Cholangitis, Sclerosing; Female; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Magneti | 2002 |
Sclerosing cholangitis associated with multifocal fibrosis: a case report.
Topics: Cholangitis, Sclerosing; Female; Humans; Middle Aged; Prednisolone; Retroperitoneal Fibrosis; Thyroi | 1992 |
[A case of primary sclerosing cholangitis with marked polyclonal hypergammaglobulinemia; effect of corticosteroid therapy].
Topics: Administration, Oral; Aged; Cholangitis, Sclerosing; Humans; Hypergammaglobulinemia; Immunoglobulin | 1992 |